Holen Sie sich die Stockscreener-App
2.16
3.57%
-0.08
Handel nachbörslich:
2.16
Schlusskurs vom Vortag:
$2.24
Offen:
$2.2
24-Stunden-Volumen:
215.72K
Relative Volume:
1.48
Marktkapitalisierung:
$110.95M
Einnahmen:
$107.88M
Nettoeinkommen (Verlust:
$-33.52M
KGV:
-3.22
EPS:
-0.6708
Netto-Cashflow:
$-11.94M
1W Leistung:
-20.00%
1M Leistung:
-35.91%
6M Leistung:
-54.81%
1J Leistung:
+44.00%
1-Tages-Spanne:
$2.14
$2.32
1-Wochen-Bereich:
$2.14
$2.7699
52-Wochen-Spanne:
$1.36
$5.33
Mdxhealth Sa Stock (MDXH) Company Profile
Firmenname
Mdxhealth Sa
Sektor
Branche
Telefon
-
Adresse
-
Compare MDXH vs TMO, DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDXH
Mdxhealth Sa
|
2.16 | 110.95M | 107.88M | -33.52M | -11.94M | -0.6708 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Mdxhealth Sa Stock (MDXH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-17 | Eingeleitet | Craig Hallum | Buy |
| 2024-10-31 | Eingeleitet | Lake Street | Buy |
| 2023-05-31 | Eingeleitet | TD Cowen | Outperform |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
Mdxhealth Sa Aktie (MDXH) Neueste Nachrichten
Health Catalyst (NASDAQ:HCAT) and MDxHealth (NASDAQ:MDXH) Head to Head Review - Defense World
MDxHealth (NASDAQ: MDXH) highlights losses, debt covenants and risk factors - Stock Titan
MDXH SEC FilingsMdxhealth Sa 10-K, 10-Q, 8-K Forms - Stock Titan
MDXH Technical Analysis & Stock Price Forecast - Intellectia AI
Stock List: Research Stocks from Around the World - GuruFocus
MDxHealth SA (NASDAQ:MDXH) Sees Significant Increase in Short Interest - marketbeat.com
MDXH Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
MDXH: William Blair to Host Virtual Meeting on March 19 - GuruFocus
MDxHealth (NASDAQ: MDXH) director reports 10,000-share option grant - Stock Titan
MVM Partners (MDXH) discloses indirect stake of 4.7M MDxHealth shares - Stock Titan
MDxHealth SA (NASDAQ:MDXH) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Mdxhealth Highlights Data from Oxford’s ProMPT Study Demonstrating the Genomic Prostate Score GPS Test Predicts Adverse Outcomes Across Multiple Treatment Settings at EAU 2026 - The Manila Times
Gene test flags prostate cancer patients who may avoid aggressive treatment - Stock Titan
MDxHealth SA (NASDAQ:MDXH) Short Interest Update - MarketBeat
MDxHealth SA Stock (ISIN: US55278X1072) Gains Momentum on Prostate Cancer Test Momentum - AD HOC NEWS
Mdxhealth Earnings Call Highlights Fast Growth, Rising Costs - TipRanks
MDxHealth Completes Bio Techne ExoDx Acquisition to Bolster Precision Diagnostics - MSN
How is MDxHealth SA managing supply chain issuesJuly 2025 Recap & Low Drawdown Investment Strategies - baoquankhu1.vn
MDXHMdxhealth Sa Latest Stock News & Market Updates - Stock Titan
BTIG reiterates MDxHealth stock rating on strong volume growth By Investing.com - Investing.com Canada
BTIG reiterates MDxHealth stock rating on strong volume growth - Investing.com
MDxHealth SA (MDXH.BR) Competitors - Meyka
Moving Averages: Whats the RSI of MDxHealth SA stockJuly 2025 Big Picture & Real-Time Market Sentiment Reports - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Short Interest Down 23.1% in February - MarketBeat
Returns Recap: What are MDxHealth SAs earnings expectationsWeekly Risk Report & Verified Short-Term Trading Plans - baoquankhu1.vn
MDXH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
MDxHealth S.A. Q4 2025 Earnings Call Summary - Yahoo Finance
Mdxhealth Q4 2025 revenue up 19% to USD 29.5M - Medical Buyer
MDxHealth ADR earnings missed by $0.04, revenue fell short of estimates - Investing.com Australia
MDxHealth SA (MDXH) Q4 2025 Earnings Call Highlights: Strong Rev - GuruFocus
MDxHealth (NASDAQ:MDXH) Announces Earnings Results - MarketBeat
MDxHealth SA (MDXH) Q4 2025 Earnings Call Transcript Summary - 富途牛牛
MDxHealth (MDXH) Q4 2025 Earnings Call Transcript - AOL.com
MDxHealth Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: MDxHealth misses Q4 2025 expectations, stock steady - Investing.com
MDXH Exceeds Revenue Expectations with Strong Q4 Performance - GuruFocus
MDxHealth SA reports results for the quarter ended December 31Earnings Summary - TradingView
MDxHealth Delivers 20% 2025 Revenue Growth and Names Interim CFO Ron Kalfus - TipRanks
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results | Associated Press | syndication news - Enidnews.com
Cancer-test maker Mdxhealth narrows 2025 loss, guides 27-30% growth for 2026 - Stock Titan
Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results - Bitget
Dow Update: Should I invest in MDxHealth SA before earningsTrade Entry Report & Free Fast Entry Momentum Trade Alerts - baoquankhu1.vn
MDxHealth SA (NASDAQ:MDXH) Given Average Rating of “Moderate Buy” by Analysts - Defense World
MDxHealth SA (NASDAQ:MDXH) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Will MDxHealth SA stock benefit from infrastructure spendingPortfolio Update Report & Free Growth Oriented Trading Recommendations - mfd.ru
MDxHealth (MDXH) Projected to Post Quarterly Earnings on Thursday - Defense World
[EFFECT] MDxHealth SA SEC Filing - Stock Titan
Medtronic Just Posted Its Best Quarter in 2.5 Years - AOL.com
Aug Outlook: Should I invest in MDxHealth SA before earningsQuarterly Trade Report & Expert Curated Trade Ideas - baoquankhu1.vn
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 - The Manila Times
MDxHealth to Release Q4 and Full Year 2025 Financial Results on February 26, 2026, Followed by Conference Call - Quiver Quantitative
Finanzdaten der Mdxhealth Sa-Aktie (MDXH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.17%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):